These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18606764)

  • 1. Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks.
    Wilson LS; Ramsey JM; Koplowicz YB; Valiente-Banuet L; Motter C; Bertozzi SM; Tobler LH
    Am J Trop Med Hyg; 2008 Jul; 79(1):53-68. PubMed ID: 18606764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region.
    Pirard M; Iihoshi N; Boelaert M; Basanta P; López F; Van der Stuyft P
    Transfusion; 2005 Apr; 45(4):554-61. PubMed ID: 15819677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new Trypanosoma cruzi antibody assay for blood donor screening.
    Gorlin J; Rossmann S; Robertson G; Stallone F; Hirschler N; Nguyen KA; Gilcher R; Fernandes H; Alvey S; Ajongwen P; Contestable P; Warren H
    Transfusion; 2008 Mar; 48(3):531-40. PubMed ID: 18067497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem.
    Kitchen AD; Hewitt PE; Chiodini PL
    Transfusion; 2012 Sep; 52(9):1931-9. PubMed ID: 22414025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors.
    Tobler LH; Contestable P; Pitina L; Groth H; Shaffer S; Blackburn GR; Warren H; Lee SR; Busch MP
    Transfusion; 2007 Jan; 47(1):90-6. PubMed ID: 17207235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing.
    O'Brien SF; Chiavetta JA; Fan W; Xi G; Yi QL; Goldman M; Scalia V; Fearon MA
    Transfusion; 2008 Apr; 48(4):755-61. PubMed ID: 18194375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge deficits regarding Chagas disease may place Mexico's blood supply at risk.
    Trivedi M; Sanghavi D
    Transfus Apher Sci; 2010 Oct; 43(2):193-6. PubMed ID: 20688572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A confirmatory diagnosis of antibodies anti-Trypanosoma cruzi in donors referred by blood banks in Venezuela].
    Díaz-Bello Z; Zavala-Jaspe R; Díaz-Villalobos M; Mauriello L; Maekelt A; de Noya BA
    Invest Clin; 2008 Jun; 49(2):141-50. PubMed ID: 18717262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of Chagas disease in blood banks in Colombia].
    Behrend M; Beltrán M; Restrepo M; Kroeger A
    Biomedica; 2002 Mar; 22(1):39-45. PubMed ID: 11957362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antibodies to Trypanosoma cruzi among solid organ donors in Southern California: a population at risk.
    Nowicki MJ; Chinchilla C; Corado L; Matsuoka L; Selby R; Steurer F; Mone T; Mendez R; Aswad S
    Transplantation; 2006 Feb; 81(3):477-9. PubMed ID: 16477238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-sialidase inhibition assay for the detection of Trypanosoma cruzi infection in blood donor samples from Argentina.
    Blejer JL; Sartor PA; Bottasso O; Salamone HJ; Leguizamón MS
    Vox Sang; 2008 Oct; 95(3):189-96. PubMed ID: 19121183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi.
    Custer B; Agapova M; Bruhn R; Cusick R; Kamel H; Tomasulo P; Biswas H; Tobler L; Lee TH; Caglioti S; Busch M
    Transfusion; 2012 Sep; 52(9):1901-11. PubMed ID: 22339233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serological screening for Trypanosoma cruzi among blood donors in central Brazil].
    de Andrade AL; Martelli CM; Luquetti AO; de Oliveira OS; Almeida e Silva S; Zicker F
    Bol Oficina Sanit Panam; 1992 Jul; 113(1):19-27. PubMed ID: 1642781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood donor screening for chagas disease--United States, 2006-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(7):141-3. PubMed ID: 17318113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines for Chagas disease: Part III. Chagas disease in donors to blood banks].
    Apt B W; Heitmann G I; Jercic L MI; Jotré M L; Muñoz C del V P; Noemí H I; San Martin V AM; Sapunar P J; Torres H M; Zulantay A I
    Rev Chilena Infectol; 2008 Aug; 25(4):285-8. PubMed ID: 18769776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain).
    Piron M; Vergés M; Muñoz J; Casamitjana N; Sanz S; Maymó RM; Hernández JM; Puig L; Portús M; Gascón J; Sauleda S
    Transfusion; 2008 Sep; 48(9):1862-8. PubMed ID: 18522707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening.
    Chang CD; Cheng KY; Jiang LX; Salbilla VA; Haller AS; Yem AW; Bryant JD; Kirchhoff LV; Leiby DA; Schochetman G; Shah DO
    Transfusion; 2006 Oct; 46(10):1737-44. PubMed ID: 17002630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic screening for Trypanosoma cruzi among blood donors in central Brazil.
    de Andrade AL; Martelli CM; Luquetti AO; de Oliveira OS; Almeida e Silva S; Zicker F
    Bull Pan Am Health Organ; 1992; 26(2):157-64. PubMed ID: 1638280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Parasitological and epidemiological aspects of Trypanosoma cruzi seropositive blood donors].
    Galaz P; García S; Mercado R; Orrego E; Pagliero B; Contreras Mdel C; Salinas P; Arancibia C
    Rev Med Chil; 2007 Oct; 135(10):1291-5. PubMed ID: 18180836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inconclusive results in conventional serological screening for Chagas' disease in blood banks: evaluation of cellular and humoral response.
    Furuchó CR; Umezawa ES; Almeida I; Freitas VL; Bezerra R; Nunes EV; Sanches MC; Guastini CM; Teixeira AR; Shikanai-Yasuda MA
    Trop Med Int Health; 2008 Dec; 13(12):1527-33. PubMed ID: 18983272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.